From Idea to Market in Eight Years, DARPA-Funded Deka Arm System Earns FDA Approval

DARPA’s Revolutionizing Prosthetics program delivers on goal of providing advanced prosthetic upper limb with near-natural control mechanisms to amputees
DARPA launched the Revolutionizing Prosthetics program with a radical goal: gain U.S. Food and Drug Administration (FDA) approval for an advanced electromechanical prosthetic upper limb with near-natural control that enhances independence and improves quality of life for amputees. Today, less than eight years after the effort was

Learn more …